The Trump administration announced price cuts for GLP-1 weight-loss drugs Zepbound and Wegovy, with direct-to-consumer access via TrumpRX in 2026.
READ: https://www.usatoday.com/story/news/politics/2025/11/06/trump-medicare-coverage-weight-loss-drugs/87122843007/
